Jump to main content

CSL Behring donates to WFH

500 Million IUs Coagulation Factor Replacement Therapy for the World Federation of Hemophilia Humanitarian Aid Program


As part of its promise to support those living with rare and serious diseases, including bleeding disorders, CSL Behring is donating 500 million international units (IUs) of coagulation factor therapy to the World Federation of Hemophilia (WFH) as part of its continued support of the WFH Humanitarian Aid Program. 

The donation, which includes product specifically manufactured for the purposes of being donated, will create consistent and reliable access to treatment for people living with bleeding disorders in more than 60 developing countries.